Sulpiride improves inadequate lactation

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Lactation Studies

Background:

• Inadequate lactation affects many new mothers, impacting infant nutrition and maternal well-being.
• Current treatments for insufficient breast milk production have varying efficacy and potential side effects.

Purpose of the Study:

• To evaluate the efficacy and safety of sulpiride in treating inadequate lactation in postpartum mothers.
• To assess the impact of sulpiride on maternal serum prolactin levels and breast milk yield.

Main Methods:

• A placebo-controlled, double-blind trial involving 28 newly delivered mothers with inadequate lactation.
• Participants received either sulpiride (50 mg thrice daily) or a placebo for four weeks.
• Measurements included serum prolactin concentrations and breast milk yields, assessed serially.

Main Results:

• Sulpiride significantly increased maternal serum prolactin levels and breast milk yields compared to placebo.
• Infants in the sulpiride group required fewer supplementary feeds and showed significantly greater weight gain.
• Mild maternal side effects were reported in the sulpiride group, with no adverse effects observed in infants.

Conclusions:

• Sulpiride is an effective and safe pharmacological intervention for managing inadequate lactation in the puerperium.
• The drug's ability to enhance prolactin secretion appears to be the primary mechanism for increasing milk production.
• Further research may explore optimal dosing and long-term effects of sulpiride for lactation support.